z-logo
open-access-imgOpen Access
Structure and functional reselection of the Mango-III fluorogenic RNA aptamer
Author(s) -
Robert J. Trachman,
Alexis Autour,
Sunny Jeng,
Amir Abdolahzadeh,
Alessio Andreoni,
Razvan Cojocaru,
Ramil Garipov,
Elena Dolgosheina,
Jay R. Knutson,
Michaël Ryckelynck,
Peter J. Unrau,
A.R. Ferré-D′Amaré
Publication year - 2019
Publication title -
nature chemical biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.412
H-Index - 216
eISSN - 1552-4469
pISSN - 1552-4450
DOI - 10.1038/s41589-019-0267-9
Subject(s) - rna , aptamer , chemistry , crystallography , fluorescence , mutant , biophysics , pyrimidine , pseudoknot , stereochemistry , biology , biochemistry , microbiology and biotechnology , physics , quantum mechanics , gene
Several turn-on RNA aptamers that activate small-molecule fluorophores have been selected in vitro. Among these, the ~30 nucleotide Mango-III is notable because it binds the thiazole orange derivative TO1-Biotin with high affinity and fluoresces brightly (quantum yield 0.55). Uniquely among related aptamers, Mango-III exhibits biphasic thermal melting, characteristic of molecules with tertiary structure. We report crystal structures of TO1-Biotin complexes of Mango-III, a structure-guided mutant Mango-III(A10U), and a functionally reselected mutant iMango-III. The structures reveal a globular architecture arising from an unprecedented pseudoknot-like connectivity between a G-quadruplex and an embedded non-canonical duplex. The fluorophore is restrained into a planar conformation by the G-quadruplex, a lone, long-range trans Watson-Crick pair (whose A10U mutation increases quantum yield to 0.66), and a pyrimidine perpendicular to the nucleobase planes of those motifs. The improved iMango-III and Mango-III(A10U) fluoresce ~50% brighter than enhanced green fluorescent protein, making them suitable tags for live cell RNA visualization.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here